(Q53384314)

13 May 2018

title

Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells. (English)

1 reference

13 May 2018

1 reference

8

M V Blagosklonny

1 reference

13 May 2018

author name string

Y Q Liu

1

1 reference

13 May 2018

E Kyle

2

1 reference

13 May 2018

S Patel

3

1 reference

13 May 2018

F Housseau

4

1 reference

13 May 2018

F Hakim

5

1 reference

13 May 2018

R Lieberman

6

1 reference

13 May 2018

M Pins

7

1 reference

13 May 2018

R C Bergan

9

1 reference

13 May 2018

publication date

1 January 2001

1 reference

13 May 2018

Prostate Cancer and Prostatic Diseases

published in

1 reference

13 May 2018

volume

4

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

81-91

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500506

exact match

0 references

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Molecular biology of prostate carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Molecular biology of prostate development and prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Clinical evidence for and implications of the multistep development of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

The multistep nature of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Molecular themes in oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Progress in cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Growth inhibition of chronic myelogenous leukemia cells by ODN-1, an aptameric inhibitor of p210bcr-abl tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Prostate cancer cell growth inhibition by tamoxifen is associated with inhibition of protein kinase C and induction of p21(waf1/cip1)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-1-integrin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Aptameric inhibition of p210bcr-abl tyrosine kinase autophosphorylation by oligodeoxynucleotides of defined sequence and backbone structure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Amplification of human beta-actin gene by the reverse transcriptase-polymerase chain reaction: implications for assessment of RNA from formalin-fixed, paraffin-embedded material

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Some recent advances in the chemistry and biology of transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 3. Oncogenes, suppressor genes, and applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Differential effects of transforming growth factor beta on human prostate cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Expression of transforming growth factor-beta 1 in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in normal and malignant human prostate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

A retrospective and prospective overview of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Expression, structure, and function of androgen receptor in advanced prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500506

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500506

1 reference

13 May 2018

1 reference

13 May 2018